Elekta Sinks as U.S. Gamma Knife Sales Seen Hit: Stockholm Mover

Elekta AB fell the most in seven months in Stockholm trading after Handelsbanken Capital Markets said new U.S. legislation will cut reimbursement for procedures using the company’s Gamma Knife radiosurgery equipment.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.